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Purpose: Sex determining region Y (SRY)-box 2 (SOX2) anophthalmia syndrome is an autosomal dominant disorder
manifesting  as  severe  developmental  eye  malformations  associated  with  brain,  esophageal,  genital,  and  kidney
abnormalities. The syndrome is usually caused by de novo mutations or deletions in the transcription factor SOX2. To
investigate any potential parental susceptibility factors, we set out to determine the parent of origin of the mutations or
deletions, and following this, to determine if birth order or parental age were significant factors, as well as whether mutation
susceptibility was related to any sequence variants in cis with the mutant allele.
Methods: We analyzed 23 cases of de novo disease to determine the parental origin of SOX2 mutations and deletions
using informative single nucleotide polymorphisms and a molecular haplotyping approach. We examined parental ages
for SOX2 mutation and deletion cases, compared these with the general population, and adjusted for birth order.
Results: Although the majority of subjects had mutations or deletions that arose in the paternal germline (5/7 mutation
and 5/8 deletion cases), there was no significant paternal bias for new mutations (binomial test, p=0.16) or deletions
(binomial test, p=0.22). For both mutation and deletion cases, there was no significant association between any single
nucleotide polymorphism allele and the mutant chromosome (p>0.05). Parents of the subjects with mutations were on
average older at the birth of the affected child than the general population by 3.8 years (p=0.05) for mothers and 3.3 years
(p=0.66) for fathers. Parents of the subjects with deletions were on average younger than the general population by 3.0
years (p=0.17) for mothers and 2.1 years (p=0.19) for fathers. Combining these data, the difference in pattern of parental
age between the subjects with deletions and mutations was evident, with a difference of 6.5 years for mothers (p=0.05)
and 5.0 years for fathers (p=0.22), with the mothers and fathers of subjects with mutations being older than the mothers
and fathers of subjects with deletions. We observed that 14 of the 23 (61%) affected children were the first-born child to
their mother, with 10/15 of the mutation cases (66%) and 4/8 deletion cases (50%) being first born. This is in comparison
to 35% of births with isolated congenital anomalies overall who are first born (p=0.008).
Conclusions: Sporadic SOX2 mutations and deletions arose in both the male and female germlines. In keeping with several
genetic disorders, we found that SOX2 mutations were associated with older parental age and the difference was statistically
significant for mothers (p=0.05), whereas, although not statistically significant, SOX2 deletion cases had younger parents.
With the current sample size, there was no evidence that sequence variants in cis surrounding SOX2 confer susceptibility
to either mutations or deletions.
Developmental  eye  malformations,  including
anophthalmia  (clinical  absence  of  the  eye)  and
microphthalmia  (small  eye),  are  a  major  cause  of  visual
impairment  worldwide.  These  conditions  are  clinically
heterogeneous,  and  can  manifest  as  either  purely  ocular
defects, or for more than half of cases, in association with
systemic anomalies [1]. Frequently, the cases display non-
Mendelian  inheritance  patterns,  reflecting  the  likely
importance  of  genetic  background  and  environmental
influences.  The  first  causative  genes,  mostly  transcription
factors  that  control  eye  morphogenetic  pathways,  are
beginning  to  be  identified,  with  dominant,  recessive,  X-
linked,  and  oligogenic  mechanisms  represented  [2–14].
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Evidence from knockout gene experiments in mice (JAX),
cytogenetic events associated with eye anomalies, and the
number of human syndromes that include anophthalmia or
microphthalmia as a clinical feature (Oxford Dysmorphology
Database 2.1), suggest that at least 200 human anophthalmia-
microphthalmia (AM) syndromes may eventually be defined.
Correlations  between  AM  and  parental  exposure  to
environmental factors around the time of conception or early
pregnancy  have  been  postulated  [15].  However,
epidemiological  studies,  by  their  nature,  group  all  AM
conditions together regardless of cause (see for example [16–
19]), whereas each might represent a distinct genetic pathway
with its own set of parameters and risk factors. Identification
of the molecular basis of individual syndromes provides an
opportunity to explore how different mutational events arise.
The  first  step  is  to  determine  parental  origin  as  this  is  a
prerequisite to understanding periconception or gestational
risk factors that contribute to disease.
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3097Herein we have set out to determine the parent of origin
for one of the earliest anophthalmic disorders to be genetically
defined,  sex  determining  region  Y  (SRY)-box  2  (SOX2;
OMIM 184429) anophthalmia syndrome. This condition is
characterized by severe, often bilateral, ocular malformations
including anophthalmia or microphthalmia with coloboma or
cyst, optic nerve hypoplasia, and rarely, retinal dystrophy
[5,6,10,20]. Clinical features also include several extraocular
features,  including  poor  growth,  cognitive  deficit,  motor
disorder, seizures, sensorineural hearing loss, mesial temporal
brain malformations, anterior pituitary hypoplasia, horseshoe
kidney, and male (and possibly female) genital abnormalities
[5,6,10,20–22].  The  syndrome  is  usually  caused  by
haploinsufficiency of SOX2, a transcription factor with a key
regulatory role in lens development [23,24]. Four families
have been described where SOX2 mutations were inherited
from a gonosomal mosaic mother [25–28]. All remaining
reported cases of SOX2 mutations and deletions have occurred
de novo. However, there is no information about the parental
origin of the mutation or deletion for any of these cases. We
used haplotype analysis to determine the parent of origin of
SOX2 mutation and deletion cases, and to investigate their
relationship with parental age and birth order. We also sought
to determine whether any sequence variants adjacent to the
SOX2 gene were associated with a susceptibility to mutation
or deletion.
METHODS
Cases: Informed consent for genetic and phenotypic analysis
was obtained from the patient and parents, in accordance with
approval by the Cambridgeshire 1 Research Ethics Committee
04/Q0104/129.  Paternity  was  confirmed  using  the
PowerPlex® 16 System (Promega, Southampton, UK). Cases
1–8 with SOX2 deletions and cases 9–19 with SOX2 mutations
have  been  previously  described  [5,6,10].  The  location  of
mutations and deletions are shown in Table 1. SOX2 deletion
and  mutation  cases  were  identified  as  de  novo  following
analysis  of  peripheral  blood  samples;  however,  it  is  not
possible to exclude parental gonosomal mosaicism. Case 19
has bilateral anophthalmia with micropenis, agenesis of the
corpus callosum, and severe developmental delay, and is most
likely to be the same case as previously reported [22]. The
proband  has  a  de  novo  heterozygous  c.479delA
(p.Tyr160Serfs*4)  mutation.  Cases  20–23  are  previously
unreported  de  novo  SOX2  mutations,  as  determined  by
analysis of peripheral blood. Case 20 is a male with right
microanterior  segment,  sclerocornea,  thin  lens,  posterior
staphyloma with hand movement vision, and left extreme
microphthalmia  (axial  length  10  mm)  with  congenital
aphakia, short stature (normal pituitary function), low weight,
unusual gait, muscle weakness, small fifth finger, dysmorphic
features,  slightly  prominent  nose,  and  has  experienced
fainting  fits.  He  had  a  c.582_592dup  (p.His198Argfs*9)
mutation.  Case  21  is  a  boy  with  isolated  bilateral
anophthalmia. There were no other systemic features apart
from  a  slightly  high  arched  palate.  The  proband  has  a  c.
143_144delinsAA mutation (p.Phe48*). Case 22 is a girl with
isolated bilateral anophthalmia. She has a de novo c.70_89del
(p.Asn24Argfs*65) mutation. Case 23 is a boy born at term
with a normal birthweight, bilateral severe microphthalmia
associated with funnel retinal detachments, and delayed motor
development.  He  has  a  de  novo  c.542delC  mutation
(p.Pro181Argfs*22).
Determining parent of origin:
Single nucleotide polymorphism genotyping—Single
nucleotide  polymorphisms  (SNPs)  surrounding  the  SOX2
genomic locale were genotyped to determine the parental
origin of sporadic SOX2 mutations and partial or whole gene
deletions. To trace the parental origin of each SOX2 deletion,
we identified cases where affected subjects failed to inherit an
SNP allele from one parent. We genotyped 24 SNPs within
50 kb of the SOX2 gene in subjects 1–8 and their parents. A
molecular haplotyping approach (described below) was used
to determine the parent of origin for the SOX2 mutations.
Genomic  DNA  was  prepared  from  peripheral  blood
samples  using  a  QIAamp  DNA  Blood  Mini  kit  (Qiagen,
Crawley, UK). For mutation and deletion cases, we genotyped
the  following  SNPs:  rs13070015,  rs9290727,  rs4434184,
rs6806029,  rs12496378,  rs12487748,  rs12497248,
rs35788479,  rs35095647,  rs11915160,  rs4575941,  and
rs4459940  (SNP).  For  deletion  cases,  we  also  genotyped
SNPs:  rs13074951,  rs13097472,  rs1558797,  rs1558798,
rs34961466, rs36062376, rs4855037, rs6443761, rs6443762,
rs6765739, rs7610679, and rs7633815. PCR products were
generated for SNPs using the primers detailed in Table 2. PCR
amplification  was  performed  in  a  50  µl  reaction  volume
containing  100  ng  DNA,  0.1  µM  each  primer,  5  µl  10×
reaction buffer, 2 µl 25 mM MgCl2, 0.2 mM dNTPs, and 2.5
Units  HotStarTaq  DNA  polymerase  (Qiagen).  Cycling
parameters were 94 °C for 15 min followed by 35 cycles at
94 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min, and a final
extension at 72 °C for 10 min. PCR products were treated with
ExoSapIT (USB) and sequenced using standard techniques.
Molecular  haplotyping—We  used  a  molecular
haplotyping approach [29] to determine the parental origin of
each SOX2 mutation. We genotyped 12 SNPs within 20 kb of
the  SOX2  gene  in  the  SOX2  mutation  subjects  and  their
parents, and identified at least one informative SNP for seven
subjects. For each of the seven informative subjects, genomic
DNA at limiting dilution was used to generate a panel of 45
aliquots  (and  one  negative  control).  Each  aliquot  was
amplified using primers for both the SOX2 CoDing Sequence
(CDS)   and    an    informative    SNP   locus   (rs11915160,
rs4459940,    or    rs4575941)    in    a    single    multiplex 
PCR. PCR products were then diluted and the SOX2 CDS and
SNP  locus  were  amplified  in  separate  monoplex  PCR
reactions  using  heminested  primers.  For  DNA  samples,
47/94±6.19 (standard deviation [SD])] aliquots were positive
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Poisson distribution of DNA fragments among the samples
[29],  this  implies  a  mean  of  0.71±0.14  (SD)  autosomal
genomes per aliquot. Aliquots positive for the presence of
both the SOX2 CDS and the informative SNP locus were then
sequenced to determine which SNP variant was associated
with the mutant SOX2 allele. A small number of aliquots were
derived from both haplotypes because they were heterozygous
for either the SOX2 mutation or the SNP locus; these did not
contribute to determine parental origin. Individual haplotypes
were reconstructed by inspection of the data and the parental
origin determined in each case. For each subject, the haplotype
was supported by odds of at least 109:1.
The  multiplex  first-phase  PCR  contained  primers  for
SOX2 and one informative SNP (rs11915160, rs4459940, or
rs4575941). Alternative SOX2 primers were used depending
on the position of the mutation. The first-phase PCR was
performed in a 10 µl reaction containing 1 µl DNA (at one
genome equivalent [3 pg/µl]), 0.04 µM each external-forward
and  -reverse  primer,  10X  reaction  buffer,  1  mM  MgCl2,
0.2 mM dNTPs and 0.5 Units HotStarTaq DNA polymerase
(Qiagen). Cycling conditions were 94 °C for 15 min followed
by 35 cycles at 94 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min,
and a final extension at 72 °C for 10 min. First-phase reaction
products were diluted to 150 µl with water and 3 µl aliquots
were  used  as  template  in  second-phase  PCR  reactions  to
independently assay SOX2 and each SNP. Second-phase PCR
was performed in a 20 µl reaction containing template DNA,
0.2 µM each internal-forward and external-reverse primer,
2 µl 10X reaction buffer, 1 mM MgCl2, 0.2 mM dNTPs, and
1  Unit  HotStarTaq  DNA  polymerase  (Qiagen).  Cycling
conditions were the same as for the first-phase PCR. Products
were analyzed by gel electrophoresis for the presence/absence
of the expected PCR product. PCR products from aliquots
positive  for  SOX2  and  the  SNP  locus  were  treated  with
ExoSapIT (USB, High Wycombe, UK) and sequenced using
standard techniques [11,12].
The confidence that can be assigned to the linkage phase
between  the  SOX2  and  SNP  loci  was  estimated  using
calculations described by Konfortov et al. [29]. This measure
depends  on  the  physical  distance  between  two  loci,  the
average fragment size of DNA in the aliquots, the number of
autosomal genomes per aliquot, and the number of genotyping
results that agree or conflict with a given haplotype phase. The
physical distance between each SOX2 mutation and the SNP
loci was calculated for each assay using genomic positions
from the UCSC genome browser [30]. Template DNA was
prepared using the QIAamp DNA Blood Mini kit (Qiagen),
which predominantly yields fragments of 20–30 kb; therefore,
we conservatively estimated average DNA fragment size at
20 kb. The number of autosomal genomes per aliquot was
estimated for each sample from the total number of positive
TABLE 1. SUMMARY OF CASES AND GENE CHANGE.
Case SOX2 gene change Reference
1 Partial gene deletion [10]
2 Whole gene deletion [10]
3 Whole gene deletion [10]
4 Whole gene deletion [10]
5 Whole gene deletion [10]
6 Whole gene deletion [10]
7 Whole gene deletion [10]
8 Whole gene deletion [10]
9 c. 529C>T; p.Q177X [5,6]
10 c.53 C>A mutation, p.S18X [10]
11 c. 248C>A, p.S83X [5,6]
12 c.70del20, p.N24fs88X [10]
13 c.480C>G, p.Y160X [10]
14 c.285dupG, p.K95fs109X [10]
15 c. 529C>T; p.Q177X [5,6]
16 c.290T>C; p.L97P [6]
17 c.70del20 p.N24fs88X [10]
18 c.188delA p.N63fs101X [10]
19 c.479delA, p.S159fs163X This study; same case likely
published [22]
20 c.582–592dup, (p.His198Argfs*9) This study
21 c.143–144TC>AA, (p.Phe48*) This study
22 c.70del20 p.N24fs88X This study
23 c.542delC, (p.Pro181Argfs*22) This study
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3099aliquots  in  the  second-phase  PCR  using  the  Poisson
distribution [29].
Sequence variant analysis: To examine whether particular
sequence variants predispose individuals to the occurrence of
mutations or deletions, we used parental data to determine the
genotype of SNPs located on mutant (mutated/deleted) and
wild-type  (nonmutated/nondeleted)  chromosomes.  For
deletion cases, we analyzed 24 SNPs, and for mutation cases
12  SNPs,  previously  genotyped  for  parental  origin.  We
compared the frequency of alleles on mutant versus wild-type
chromosomes using Fisher’s exact test.
Parental  age:  To  examine  parental  age  effects  in  SOX2
anophthalmia  syndrome,  the  median  ages  of  parents  of
affected subjects were compared with median parental age at
birth of the general population using the national birth cohorts
of England and Wales for the relevant years of birth of the
affected subjects; paternal age was not available for two of the
children. Given the sparse numbers in the affected group, the
distribution of parental age is uncertain and therefore medians
were calculated and compared using the Mann–Whitney U-
test  (Table  3).  General  population  comparison  data  were
obtained from the national birth statistics for England and
Wales published by the Office for National Statistics, Birth
Statistics 1985 to 2007, Series FM1, London: ONS, 1988 to
2009.
Fourteen  of  the  23  children  were  first  births  to  their
mothers. To take into account the potential confounding effect
of birth order, the birth order–specific mean maternal age of
the general population was extracted for the birth year of each
affected child. Data to enable birth order to be accounted for
in relation to paternal age are not published; thus, the overall
mean general population paternal age was extracted for the
year of birth of each of the affected children. Data on birth
order of the affected children were compared with data from
the  Congenital  Anomalies  Register  for  Oxfordshire,
Berkshire and Buckinghamshire (CAROBB), as cases from
the  England  and  Wales  National  Congenital  Anomalies
System are known to be underascertained and not published
by birth order.
RESULTS
Parent of origin: Deletion cases: The majority of subjects
(5/8) had deletions that arose in the paternal germline, but this
did not represent a statistically significant paternal bias to the
a  priori  assumption  that  deletions  occur  with  the  same
probability on maternal and paternal chromosomes (binomial
test, p=0.22).
Mutation cases: In the majority of subjects (5/7), the
mutation  was  paternal  in  origin,  although  this  does  not
represent a statistically significant paternal bias to the a priori
assumption that mutations occur with the same probability on
maternal and paternal chromosomes (binomial test, p=0.16).
For  both  mutation  and  deletion  cases,  there  was  no
significant association between any SNP allele and the mutant
chromosome (p>0.05). With the current sample size, there is
no evidence that in cis sequence variants surrounding SOX2
confer susceptibility to either mutations or deletions.
TABLE 2. PCR PRIMERS FOR SNP ANALYSIS.
SNP Forward 5′-3′ Reverse 5′-3′
rs13070015 CCAGGATTGGAGACCTTACTG GGTTGGGGGAGAGGAGATAA
rs9290727 CAGCGTCTTGAATGCCCTCAG GGATTCCTGGTCAACGAAATGC
rs4434184 ATCACTCAGACGGGCAGATAAG TCAGATGGAGTTGGGTTTCC
rs6806029/rs12496378 TGCCAAACACATCAGCCCTCTG GGGCTACCCTTTCACTGCAAGG
rs12487748/ rs12497248 AGCTGTAGTGCAGGGATAGAATCTTAAC AGAACAGCTTTGCATTCAGCTCC
rs35788479 CGTGGAAGGGAAGTGTTACACTCC GCCCACTCTATTTCAATCCAGCAC
rs35095647 AGGTAAGAGAGGAGAGCGGAAGAGC CAGCAACAGGTCACACCACACG
rs11915160 GTACGGTAGGAGCTTTGCAGGAAG TGTCCTAAATTTCAGCTGCAGAATC
rs4575941/rs4459940 GGGTCAAAGAGCAATGCTTCAA CCCCTTTTGCCCCATATTGC
rs34961466/rs13074951/rs13097472 CCAAGCCTGTAGCCCCAAAT GGTGGGTGGTGATGCAGAAG
rs4855037/rs1558797/rs1558798 GCTTGCAGTGAGCAGAGATCGC TGGGACGCAAACCTTGACAGTC
rs7633815/rs36062376 GGAGTTTCTCATTCCCTGCTC CTCTGCTTCCTGGGTTCAAG
rs6443761/rs6443762 GCCTTCACTCTGTCACCCTATCTG TTTGGCCGGTTCTGAATCTGACTAC
rs6765739 AGGCTCGTGGCTTAGGAGATTG AAATAGCCACTGAAAGGCAAGGTC
rs7610679 TCAAGAAGACAGAACTGCCAAGAGG CCCTTCTTCTACCCTCCCATTCC
SOX2 5′ outer TACAACATGATGGAGACGGAGCTGA TGCGAGCTGGTCATGGAGTTG
SOX2 5′ inner GGTAGCCCAGCTGGTCCTG  
SOX2 3′ outer GGCGTGAACCAGCGCATGG TCATTTGCTGTGGGTGATGGG
SOX2 3′ inner GAGCGTACCGGGTTTTCTC  
rs11915160 outer CCAATCCCATCCACACTCACG TGTCCTAAATTTCAGCTGCAGAATC
rs11915160 inner GTACGGTAGGAGCTTTGCAGGAAG  
rs4575941/rs4459940 outer GGGTCAAAGAGCAATGCTTCAA GGCAAAGGTTGTAAATGAGCACC
rs4575941/rs4459940 inner CCCCTTTTGCCCCATATTGC  
Molecular Vision 2011; 17:3097-3106 <http://www.molvis.org/molvis/v17/a333> © 2011 Molecular Vision
3100T
A
B
L
E
 
3
.
 
P
A
R
E
N
T
A
L
 
A
G
E
 
A
T
 
T
H
E
 
B
I
R
T
H
 
O
F
 
T
H
E
 
A
N
O
P
H
T
H
A
L
M
I
A
 
S
U
B
J
E
C
T
S
 
C
O
M
P
A
R
E
D
 
W
I
T
H
 
P
A
R
E
N
T
A
L
 
A
G
E
 
I
N
 
T
H
E
 
G
E
N
E
R
A
L
 
P
O
P
U
L
A
T
I
O
N
 
O
F
 
B
I
R
T
H
S
 
F
O
R
 
E
N
G
L
A
N
D
 
A
N
D
 
W
A
L
E
S
.
P
a
r
e
n
t
a
l
 
a
g
e
 
c
o
m
p
a
r
i
s
o
n
s
N
u
m
b
e
r
 
o
f
a
n
o
p
h
t
h
a
l
m
i
a
s
u
b
j
e
c
t
s
P
a
r
e
n
t
s
 
o
f
 
a
n
o
p
h
t
h
a
l
m
i
a
s
u
b
j
e
c
t
s
P
a
r
e
n
t
a
l
 
a
g
e
 
a
t
 
b
i
r
t
h
 
f
o
r
 
t
h
e
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
3
D
i
f
f
e
r
e
n
c
e
 
i
n
a
g
e
 
(
y
e
a
r
s
)
p
 
v
a
l
u
e
4
D
e
l
e
t
i
o
n
s
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
p
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
8
3
0
.
0
 
(
2
4
.
0
–
3
4
.
0
)
3
2
.
1
 
(
3
0
.
0
–
3
2
.
2
)
−
2
.
1
1
0
.
1
9
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
m
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
8
2
4
.
5
 
(
2
1
.
0
–
3
0
.
0
)
2
7
.
5
 
(
2
6
.
5
–
3
1
.
0
)
−
3
.
0
1
0
.
1
7
M
u
t
a
t
i
o
n
s
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
p
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
1
3
3
5
.
0
 
(
1
8
.
0
–
4
4
.
0
)
3
1
.
7
 
(
2
9
.
7
–
3
2
.
4
)
+
3
.
3
1
0
.
6
6
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
m
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
1
5
3
1
.
0
 
(
1
8
.
0
–
4
1
.
0
)
2
7
.
2
 
(
2
5
.
1
–
3
2
.
4
)
+
3
.
8
1
0
.
0
5
P
a
t
e
r
n
a
l
 
a
g
e
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
p
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
 
o
f
 
s
u
b
j
e
c
t
s
 
w
i
t
h
d
e
l
e
t
i
o
n
s
8
3
0
.
0
 
(
2
4
.
0
–
3
4
.
0
)
-
+
5
.
0
2
0
.
2
2
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
p
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
 
o
f
 
s
u
b
j
e
c
t
s
 
w
i
t
h
m
u
t
a
t
i
o
n
1
3
3
5
.
0
 
(
1
8
.
0
–
4
4
.
0
)
-
 
 
M
a
t
e
r
n
a
l
 
a
g
e
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
m
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
 
o
f
 
s
u
b
j
e
c
t
s
 
w
i
t
h
d
e
l
e
t
i
o
n
s
8
2
4
.
5
 
(
2
1
.
0
–
3
0
.
0
)
-
+
6
.
5
2
0
.
0
5
M
e
d
i
a
n
 
(
r
a
n
g
e
)
 
m
a
t
e
r
n
a
l
 
a
g
e
 
i
n
 
y
e
a
r
s
 
o
f
 
s
u
b
j
e
c
t
s
 
w
i
t
h
m
u
t
a
t
i
o
n
1
5
3
1
.
0
 
(
1
8
.
0
–
4
1
.
0
)
-
 
 
1
T
h
e
 
d
i
f
f
e
r
e
n
c
e
 
i
s
 
t
h
e
 
m
e
d
i
a
n
 
p
a
r
e
n
t
a
l
 
a
g
e
 
o
f
 
a
n
o
p
h
t
h
a
l
m
i
a
 
s
u
b
j
e
c
t
s
 
m
i
n
u
s
 
t
h
e
 
m
e
d
i
a
n
 
p
a
r
e
n
t
a
l
 
a
g
e
 
i
n
 
t
h
e
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
.
 
2
T
h
e
 
d
i
f
f
e
r
e
n
c
e
 
i
s
 
t
h
e
 
m
e
d
i
a
n
 
p
a
r
e
n
t
a
l
a
g
e
 
o
f
 
a
n
o
p
h
t
h
a
l
m
i
a
 
m
u
t
a
t
i
o
n
 
c
a
s
e
s
 
m
i
n
u
s
 
t
h
e
 
m
e
d
i
a
n
 
p
a
r
e
n
t
a
l
 
a
g
e
 
o
f
 
a
n
o
p
h
t
h
a
l
m
i
a
 
d
e
l
e
t
i
o
n
 
c
a
s
e
s
.
 
3
M
e
d
i
a
n
 
o
f
 
t
h
e
 
b
i
r
t
h
 
y
e
a
r
-
s
p
e
c
i
f
i
c
 
g
e
n
e
r
a
l
 
p
o
p
u
l
a
t
i
o
n
 
m
e
a
n
s
.
4
P
-
v
a
l
u
e
s
 
d
e
r
i
v
e
d
 
f
r
o
m
 
t
h
e
 
M
a
n
n
–
W
h
i
t
n
e
y
 
U
 
t
e
s
t
.
Molecular Vision 2011; 17:3097-3106 <http://www.molvis.org/molvis/v17/a333> © 2011 Molecular Vision
3101We  were  unable  to  determine  parental  origin  in  the
remaining eight cases because SNPs were uninformative (4
cases) or DNA samples were unavailable (4 cases).
Parental age: Parents of the subjects with mutations were on
average older at the birth of the affected child than the general
population by 3.8 years (p=0.05) for mothers and 3.3 years
(p=0.66) for fathers. In contrast, the parents of the subjects
with  deletions  were  on  average  younger  than  the  general
population by 3.0 years (p=0.17) for mothers and 2.1 years
(p=0.19) for fathers. The difference in pattern of parental age
was evident in the comparison of parental age between the
subjects with deletions and mutations, with a difference of 6.5
years for mothers (p=0.05) and 5.0 years for fathers (p=0.22),
with the mothers and fathers of subjects with mutations being
older than the mothers and fathers of subjects with deletions.
We observed that 14 of the 23 (61%) affected children were
the first-born child to their mother, with 10/15 of the mutation
cases (66%) and 4/8 deletion cases (50%) being first born.
This is in comparison to 35% of births with isolated congenital
anomalies  overall  who  are  first  born  (p=0.008;  P  Boyd,
CAROBB, personal communication).
DISCUSSION
The parental origin of de novo genetic anomalies depends on
several factors. First, the type of genetic defect is often parent
specific. Spontaneous base substitutions are thought to occur
preferentially  in  the  paternal,  rather  than  the  maternal,
germline because of the higher number of cell divisions in
spermatogenesis than oogenesis [31]. This is supported by
evidence  from  several  disorders,  where  spontaneous  base
substitutions  arise  predominantly  in  the  paternal  germline
[32,33].  In  contrast,  certain  spontaneous  chromosomal
abnormalities are more commonly maternal in origin, such as
those  causing  Duchenne  muscular  dystrophy  or
neurofibromatosis [34,35]. Second, a genetic anomaly might
have a selective advantage or disadvantage in male or female
germ cells. For example, positive selection of sperm with
mutations  in  FGFR2  in  the  male  germline  is  thought  to
contribute to the paternal age effect in Apert syndrome [36].
Third, parental origin might depend on which parent has been
exposed  to  environmental  hazards  that  cause  germline
mutations [37].
SOX2  anophthalmia  syndrome  can  occur  through
structural rearrangement of 3q21 [5,38,39], whole or partial
gene deletions [10], intragenic insertions, deletions, or point
mutations  [5,6,10,20–22,39,40],  leading  to  SOX2
haploinsufficiency. The majority of cases are de novo, with
occasional  cases  resulting  from  parental  gonosomal
mosaicism [25–28]. A potential parental bias for gonosomal
mosaicism exists because all cases reported to date are  mat-
ternal in origin. Nevertheless, it is still necessary to test both
parents of a proband, preferably using more than one tissue
type (blood and buccal cells) to determine if a parent is mosaic
to enable accurate  genetic counselling. There have been no
described cases of inherited SOX2 mutations or deletions,
most likely because of reduced genetic fitness, in addition to
male and possibly female genital abnormalities, some related
to hypothalamic-pituitary axis dysfunction.
The  majority  of  the  informative  SOX2  anophthalmia
mutation (5/7) and deletion (5/8) cases were paternal in origin,
although this does not represent a statistically significant bias
in distribution in favor of paternal origin. Previous studies
have identified disorders with an exclusively paternal origin,
such  as  achondroplasia  and  Apert  syndrome  [41,42],  in
addition to those with weaker paternal origin effects, such as
neurofibromatosis,  retinoblastoma,  Sotos  syndrome,  and
Treacher-Collins  syndrome  [43–46].  Disorders  with  an
exclusively  paternal  origin  are  characterized  by  a  narrow
mutational  range.  For  example,  >99%  of  sporadic
achondroplasia  is  caused  by  p.Gly380Arg  mutations  in
FGFR3 [47,48] and >98% of sporadic Apert syndrome is
caused  by  p.Ser252Trp  or  p.Pro253Arg  mutations  in
FGFR2 [41,49]. Typically, disorders with weaker paternal
origin  effects  have  wider  mutational  ranges,  with  base
substitutions  comprising  a  smaller  proportion  of  the  total
number of mutations. For example, one study found that only
42%  of  retinoblastoma  germline  mutations  are  base
substitutions, with 15% comprising large deletions and 26%
small insertions/deletions [50].
Consistent  with  the  absence  of  a  significant  paternal
origin effect, SOX2 anophthalmia syndrome is characterized
by a wide mutation spectrum. Of the 15 cases examined here,
there were 13 different mutations. Only seven mutations were
base  substitutions,  with  the  remainder  single  nucleotide
(three)  or  polynucleotide  (three)  additions  or  deletions.
Furthermore, none of the mutation events in our cohort is a
C>T transition at a CpG dinucleotide, which occur when
methylated cytosine is deaminated to thymine. The absence
of C>T transitions at CpG dinucleotides is unusual given that
the SOX2 coding sequence overlaps with a CpG island [51].
Only two identified mutations in our cohort were present in
more  than  one  individual:  c.529C>T  (p.Gln177*)  and  c.
70_89del (p.Asn24Argfs*65) in published cases 12 and 17,
and  the  new  case  22.  The  c.70_89del  (p.Asn24Argfs*65)
mutation  has  also  been  noted  in  eight  other  published
anophthalmia cases summarized by Schneider and colleagues
[28], including one pair of monozygotic twins discordant for
anophthalmia  [40].  The  similar  c.70_86del
(p.Asn24Glyfs*66)  mutation  has  also  been  noted  in  two
siblings discordant for anophthalmia [26]. The c.70_89del
(p.Asn24Argfs*65) mutation results in the deletion of one of
a pair of direct 5′-[GCG]3GC-3′ repeats, and the intervening
nine  nucleotides.  The  c.70_86del  (p.Asn24Glyfs*66)
mutation results in the deletion of one of the 5′-[GCG]2GC-3′
repeats, and the intervening nine nucleotides. We were able
to  determine  parental  origin  for  one  of  the  c.70_89del
(p.Asn24Argfs*65) cases in our cohort, and found that the
mutation was paternally derived. Previous studies have found
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and arises during replication by a mispairing of direct repeats
(see [52]).
Sporadic cases of several disorders are associated with
older paternal age (reviewed in [32]) or rarely with younger
maternal age [53–55]. We found the mutation cases were
associated with older parental age, although this was only
statistically significant for the mothers. The small number of
mutation cases of paternal origin (n=13) means that chance
cannot be excluded as an explanation for this finding, but the
absence of a paternal age effect is consistent with the absence
of a paternal origin bias. One possible explanation for the
maternal age association is that DNA repair mechanisms are
maternally derived from mRNA and protein in the oocyte. For
example,  female  mice  deficient  in  double-stranded  break
repair  do  not  efficiently  repair  double-strand  breaks  that
originally arose in sperm [56,57]. Therefore, the ability of the
mother to correct a genetic defect at oogenesis or during the
first cell division after zygosis is critical [58], and this may be
impaired with increasing age.
In contrast, we found the deletion cases had parents who
were on average younger by two to three years than parents
in general, and this difference is substantial in population
terms.  These  results  were,  however,  not  statistically
significant;  that  is,  with  only  eight  cases  in  total,  these
comparisons  lacked  the  statistical  power  to  unmask  what
might  be  a  real  and  important  finding  that  merits  further
investigation.  Younger  maternal  age  has  previously  been
noted in several disorders, including septo-optic dysplasia
[53],  cleft  lip,  central  nervous  system  anomalies,
gastroschisis,  and  skin,  upper  limb  and  female  genital
anomalies [54,59,60]. One possible reason for this is a greater
likelihood  of  the  survival  of  malformed  conceptuses  in
younger women, which is consistent with the finding that the
frequency of chromosomally normal spontaneous abortions
increases with maternal age [61]. Several studies have also
drawn attention to the role of lifestyle factors in the etiology
of  anomalies  associated  with  younger  maternal  age.  For
example,  drug  and  alcohol  consumption  and  cigarette
smoking  have  been  implicated  in  the  risk  of  specific
congenital  anomalies  that  tend  to  occur  predominantly  in
younger women, for example, gastroschisis [60,62] and optic
nerve  hypoplasia  [55,63,64].  With  our  relatively  small
number  of  cases,  we  were  unable  to  explore  further  the
relationship between lifestyle and/or environmental factors
and the occurrence of SOX2 deletions or mutations. Such
investigations will require an international collaborative effort
to identify sufficient cases to explore this further. However,
this would clearly be worthwhile if this is able to shed light
on the causal mechanisms leading to SOX2 mutational events,
which  have  such  a  profound  impact  on  the  children  and
families affected.
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